Exane Derivatives Mannkind Corp Transaction History

Exane Derivatives

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	SELL	$2.62 - $4.45 $0 - $0	0 Closed	0 $0
Q4 2021 Jan 28, 2022	BUY	$4.05 - $5.37 $0 - $0	0 New	0 $0
Q3 2021 Oct 26, 2021	SELL	$3.89 - $5.48 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$3.61 - $5.45 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$3.14 - $6.14 $0 - $0	0 New	0 $0
Q4 2020 Jan 27, 2021	SELL	$1.79 - $4.04 $14 - $32	-8 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$1.15 - $2.29 $9 - $18	8	8 $0

244

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.57B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.